CLINICAL EXPERIENCE WITH N-HEXAMETHYLENE N'N'-DIETHYLENE THIOPHOSPHORAMIDE (KC-33), A NEW AGENT FOR BREAST AND OVARIAN CARCINOMA.
D000970:Antineoplastic Agents; D001201:Ascites; D035843:Biomedical Research; D001943:Breast Neoplasms; D004358:Drug Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D010051:Ovarian Neoplasms; D010996:Pleural Effusion; D014116:Toxicology
D000970:Antineoplastic Agents
ANTINEOPLASTIC AGENTS; ASCITES; BREAST NEOPLASMS; CLINICAL RESEARCH; DRUG THERAPY; LUNG NEOPLASMS; MICE; NEOPLASM THERAPY; OVARIAN NEOPLASMS; PLEURAL EFFUSION; TOXICOLOGIC REPORT